Drug
Spt 300
Spt 300: highest development phase Phase 2, developed by Seaport Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Seaport Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPT-300 NCT07065240 | Phase 2 | Major Depressive Disorder (MDD) |
| SPT-300 NCT07161700 | Phase 2 | Major Depressive Disorder (MDD) |
Latest
No recent events.
Follow Spt 300 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.